Nedira was Vice President of Business Development at NeuroSense Therapeutics, and Chief Executive Officer at Salzman Group. Nedira Salzman-Frenkel joined BioHarvest Sciences in 2026.
Nedira Salzman-Frenkel is currently
Create your alert
to follow the career of Nedira Salzman-Frenkel.
Nedira Salzman-Frenkel has a Master in Biochemistry from Hebrew University of Jerusalem in 2013 and a Master of Business Administration in Entrepreneurship and Strategy from Tel Aviv University - Coller School of Management in 2017.
They have also studied at Hebrew University of Jerusalem :
Find more alumni from Hebrew University of Jerusalem
Do you need to know more about Nedira Salzman-Frenkel? More results.
Report an error
Update the org chart details of Nedira Salzman-Frenkel.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.